← SynDRA
PARTHENOLIDE
SynDRA canonical compound SYN0017692 — structure-anchored drug synonym record
| Clinical phase | Phase 1 |
| Mechanism of action | NFkB pathway inhibitor |
All known targets
- HDAC1
- IKBKB
- NFKB1; NFKB2; RELA; RELB; REL
Mechanisms of action (all sources)
- NFkB pathway inhibitor
- IKBKB INHIBITOR
- Inhibitor
Cross-references
Synonyms
- NSC-157035
- (-)-Parthenolide
- CHEBI:7939
- Parthenolide, Tanacetum parthenium
- 4,5-alpha-Epoxy-6-beta-hydroxygermacra-1(10),11(13)-dien-12-oic acid gamma-lactone
- partenolide
- C15H20O3
- Prestwick2_000550
- Prestwick3_000550
- Epitope ID:115014
- SCHEMBL8220
- BSPBio_001308
- BSPBio_000599
- MLS002153872
- CHEMBL465158
- BPBio1_000659
- SCHEMBL13367522
- BCBcMAP01_000041
- Parthenolide, >
- MolPort-008-268-168
- MolPort-003-959-089
- HMS1361B10
- HMS3402B10
- HMS1989B10
- HMS1791B10
- HMS1569N21
- HMS2096N21
- MFCD00134592
- (1aR,4E,7aS,10aS,10bR)-1a,5-dimethyl-8-methylidene-2,3,6,7,7a,8,10a,10b-octahydrooxireno[9,10]cyclodeca[1,2-b]furan-9(1aH)-one
- (1S,2R,4R,7E,11S)-4,8-dimethyl-12-methylidene-3,14-dioxatricyclo[9.3.0.02,4]tetradec-7-en-13-one
- 2RDB26I5ZB
- NSC 157035
- PARTHENOLIDE [MI]
- PARTHENOLIDE [INCI]
- PARTHENOLIDE [USP-RS]
- PARTHENOLIDE [WHO-DD]
- parthenolide-(alternate-stereo)
- Parthenolide, >=98% (HPLC)
Look up PARTHENOLIDE in the interactive SynDRA portal →